Screening compound: C31H33N3O5S2 (C064-0331)

Screening compound: C<sub>31</sub>H<sub>33</sub>N<sub>3</sub>O<sub>5</sub>S<sub>2</sub> (C064-0331)
Screening compound: C<sub>31</sub>H<sub>33</sub>N<sub>3</sub>O<sub>5</sub>S<sub>2</sub> (C064-0331) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C31H33N3O5S2 (C064-0331)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C064-0331

Molecular Formula

C31H33N3O5S2 (C31 H33 N3 O5 S2)

Compound Name

ethyl 2-{2-[(1-{2-[(4-ethoxyphenyl)formamido]ethyl}-1H-indol-3-yl)sulfanyl]acetamido}-4H,5H,6H-cyclopenta[b]thiophene-3-carboxylate

IUPAC name

ethyl 2-{2-[(1-{2-[(4-ethoxyphenyl)formamido]ethyl}-1H-indol-3-yl)sulfanyl]acetamido}-4H5H6H-cyclopenta[b]thiophene-3-carboxylate

SMILES

CCOC(c1c(NC(CSc2cn(CCNC(c(cc3)ccc3OCC)=O)c3c2cccc3)=O)sc2c1CCC2)=O

InChI

InChI=1S/C31H33N3O5S2/c1-3-38-21-14-12-20(13-15-21)29(36)32-16-17-34-18-26(22-8-5-6-10-24(22)34)40-19-27(35)33-30-28(31(37)39-4-2)23-9-7-11-25(23)41-30/h5-6,8,10,12-15,18H,3-4,7,9,11,16-17,19H2,1-2H3,(H,32,36)(H,33,35)

InChI Key

NUHSOKNSOOHIHL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD04454381

C31H33N3O5S2 (C064-0331) in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Annotated Library (21441 compounds)

Human GPCR Annotated Library (5539 compounds)

Human Proteases Annotated Library (2868 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C31H33N3O5S2 (C064-0331) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C31H33N3O5S2 (C064-0331)?
Check Price and Availability of C31H33N3O5S2 (C064-0331), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C31H33N3O5S2 (C064-0331) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C31H33N3O5S2 (C064-0331)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C31H33N3O5S2 (C064-0331)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C31H33N3O5S2 (C064-0331) available by request